Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Net Income (2022 - 2025)

Historic Net Income for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to -$5.1 million.

  • bioAffinity Technologies' Net Income fell 15244.82% to -$5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$14.7 million, marking a year-over-year decrease of 7450.88%. This contributed to the annual value of -$9.0 million for FY2024, which is 1389.47% down from last year.
  • As of Q3 2025, bioAffinity Technologies' Net Income stood at -$5.1 million, which was down 15244.82% from -$4.1 million recorded in Q2 2025.
  • Over the past 5 years, bioAffinity Technologies' Net Income peaked at -$88052.0 during Q2 2022, and registered a low of -$5.1 million during Q3 2025.
  • Over the past 4 years, bioAffinity Technologies' median Net Income value was -$2.1 million (recorded in 2024), while the average stood at -$2.5 million.
  • Within the past 5 years, the most significant YoY rise in bioAffinity Technologies' Net Income was 5343.22% (2023), while the steepest drop was 187630.15% (2023).
  • bioAffinity Technologies' Net Income (Quarter) stood at -$1.7 million in 2022, then tumbled by 41.72% to -$2.4 million in 2023, then dropped by 25.02% to -$3.0 million in 2024, then plummeted by 70.25% to -$5.1 million in 2025.
  • Its Net Income stands at -$5.1 million for Q3 2025, versus -$4.1 million for Q2 2025 and -$2.7 million for Q1 2025.